Literature DB >> 26182685

Comparison of Molecular Multiplex and Singleplex Analysis of IgE to Grass Pollen Allergens in Untreated German Grass Pollen-Allergic Patients.

C Ahlgrim, J Gutermuth, A Onell, M P Borres, I Schäffner, U Darsow, F Pfab, K Brockow, J Ring, H Behrendt, T Jakob.   

Abstract

BACKGROUND: The ImmunoCAP ISAC 112 platform is the only commercially available molecular allergy IgE multiplex test. Data on the comparison of this rather novel test with the molecular singleplex ImmunoCAP IgE platform are lacking.
OBJECTIVE: To compare the multiplex ISAC 112 platform and the singleplex ImmunoCAP platform in regard to IgE to grass pollen allergens in untreated grass pollen-allergic patients in Germany.
METHODS: Serum samples from 101 adults with grass pollen allergy were analyzed for specific IgE (sIgE) to 8 allergenic molecules from timothy grass pollen and to the 112 allergenic molecules included in the ISAC panel. The results for the multiplex and singleplex tests were subsequently analyzed statistically.
RESULTS: Comparison of sIgE to grass pollen allergens detected by ISAC 112 and the singleplex ImmunoCAP assay revealed the following correlation coefficients: 0.88 (rPhl p 1), 0.96 (rPhl p 2), 0.70 (nPhl p 4), 0.94 (rPhl p 5b), 0.92 (rPhl p 6), 0.85 (rPhl p 11), and 0.78 (rPhl p 12).
CONCLUSION: Molecular testing with ISAC 112 correlates well with the ImmunoCAP platform for respective molecular timothy grass pollen allergens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26182685

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  9 in total

Review 1.  How In Vitro Assays Contribute to Allergy Diagnosis.

Authors:  Anne Casset; Naji Khayath; Frédéric de Blay
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 2.  The use of microarray and other multiplex technologies in the diagnosis of allergy.

Authors:  Behnam Keshavarz; Thomas A E Platts-Mills; Jeffrey M Wilson
Journal:  Ann Allergy Asthma Immunol       Date:  2021-01-12       Impact factor: 6.248

3.  Debates in allergy medicine: Molecular allergy diagnosis with ISAC will replace screenings by skin prick test in the future.

Authors:  E Jensen-Jarolim; A N Jensen; G W Canonica
Journal:  World Allergy Organ J       Date:  2017-09-19       Impact factor: 4.084

4.  Precision medicine allergy immunoassay methods for assessing immunoglobulin E sensitization to aeroallergen molecules.

Authors:  Florin-Dan Popescu; Mariana Vieru
Journal:  World J Methodol       Date:  2018-11-29

Review 5.  Diagnostic Tools in Allergic Rhinitis.

Authors:  Almudena Testera-Montes; Raquel Jurado; Maria Salas; Ibon Eguiluz-Gracia; Cristobalina Mayorga
Journal:  Front Allergy       Date:  2021-09-23

6.  Microarray Analysis Confirms ImmunoCAP-Fluorescence Enzyme Immunoassay Results on Specific IgE in Patients with Atopic Dermatitis and Suspected Birch Pollen-Related Food Allergy.

Authors:  Anja Wassmann-Otto; Annice Heratizadeh; Katja Wichmann; Thomas Werfel
Journal:  Int Arch Allergy Immunol       Date:  2022-04-04       Impact factor: 3.767

7.  Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis.

Authors:  Johannes Huss-Marp; Jan Gutermuth; Ina Schäffner; Ulf Darsow; Florian Pfab; Knut Brockow; Johannes Ring; Heidrun Behrendt; Thilo Jakob; Christoph Ahlgrim
Journal:  Allergo J Int       Date:  2015-03-14

8.  Pilot study: assessing the clinical diagnosis of allergy in atopic children using a microarray assay in addition to skin prick testing and serum specific IgE.

Authors:  Ru-Xin Foong; Graham Roberts; Adam Tobias Fox; George du Toit
Journal:  Clin Mol Allergy       Date:  2016-08-19

9.  Sensitization to PR-10 proteins is indicative of distinctive sensitization patterns in adults with a suspected food allergy.

Authors:  Mark A Blankestijn; André C Knulst; Edward F Knol; Thuy-My Le; Heike Rockmann; Henny G Otten; Rob J B Klemans
Journal:  Clin Transl Allergy       Date:  2017-11-23       Impact factor: 5.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.